Pulmicort CFC-free range

In line with the global phase-out of chlorofluorocarbon (CFC)-containing inhalers in favour of inhalers that use more environmentally friendly CFC-free propellants, AstraZeneca has launched Pulmicort (budesonide) 200 microgram CFC-free metered dose inhaler (MDI).

This is the latest addition to the company's range of CFC-free MDIs, which includes the Pulmicort 100 microgram CFC-free MDI.

View Pulmicort CFC-free drug record

Further information: AstraZeneca

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more